US Market Report for Insulin Syringes 2017 - MedCore

NEW YORK, Dec. 13, 2016 /PRNewswire/ --

Description
The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segment. Although conventional insulin syringes were once a popular method of insulin delivery, patients are transitioning towards new technologies such as insulin pens and pumps. Unit sales will continue to decline over the forecast period in conjunction with the growing penetration rate of insulin pens, as well as the growing penetration rate of insulin pumps among the type 2 insulin-dependent patient population. Mild ASP depreciation will also contribute to erosion in the value of the conventional insulin syringe market.
Abstract
Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Although many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, syringes are still the most widely used device to inject insulin. Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.
Scope:2013-2023
Companies
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
Read the full report: http://www.reportlinker.com/p04353022-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

Contact Clare:
clare@reportlinker.comUS: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-market-report-for-insulin-syringes-2017---medcore-300377681.html

SOURCE Reportlinker